Alexandria Real Estate Equities
ARE
#2226
Rank
โ‚น770.77 B
Marketcap
โ‚น4,448
Share price
-1.60%
Change (1 day)
-44.96%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚น89.1 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.94 Billion. a decrease over its 2024 earnings that were of โ‚น65.38 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น92.94 Billion-242.13%
2024 โ‚น65.38 B96.11%
2023 โ‚น33.34 B-53.56%
2022 โ‚น71.80 B-3.96%
2021 โ‚น74.76 B-20.26%
2020 โ‚น93.75 B72.88%
2019 โ‚น54.23 B3.11%
2018 โ‚น52.59 B73.54%
2017 โ‚น30.30 B464.88%
2016 โ‚น5.36 B-77.32%
2015 โ‚น23.65 B36.31%
2014 โ‚น17.35 B-10.81%
2013 โ‚น19.45 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น956.73 B-1,129.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.415 T-2,699.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น842.58 B-1,006.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น919.65 B-1,089.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น111.33 B-219.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น875.62 B-1,042.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น54.04 B-158.16%๐Ÿ‡บ๐Ÿ‡ธ USA